Teva Pharmaceutical Industries LimitedPetah Tikva, Israel (NASDAQ (GS): TEVA)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Teva Pharmaceuticals Financial Statements

Teva Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Teva Pharmaceuticals Income Statement

  2007 2006 2005
Revenue ($ mil.) 9,408.0 8,408.0 5,250.4
Gross Profit ($ mil.) 4,877.0 4,259.0 2,480.6
Operating Income ($ mil.) 2,395.0 801.0 1,312.9
Total Net Income ($ mil.) 1,952.0 546.0 1,072.3
Diluted EPS (Net Income) -- -- 1.59
More Teva Pharmaceuticals financial information

Teva Pharmaceuticals Stock Quote & Chart

08/29/08 15:00:10 EST • NASDAQ • 47.34 • Decreased by -0.1600 • Decreased by -0.3368 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Teva Pharmaceuticals Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.96 3.53 1.56
Price/Earnings Ratio -- 15.32 15.80
Price/Book Ratio 2.03 2.96 1.51
Price/Cash Flow Ratio 15.35 12.69 9.70
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Teva Pharmaceuticals Financial Ratios

Teva Pharmaceuticals Competitive Intelligence

Barr Pharmaceuticals Sandoz International GmbH Watson Pharmaceuticals
Annual Sales ($ mil.) 2,500.6 3,045.0 2,496.6
Employees 8,900 13,397 56,400
Market Cap ($ mil.) 7,261.2 -- 3,081.3

Competitive Landscape